How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion biotech powerhouse that's poised to reshape biotechBusiness Insider • 11/21/20
Moderna: I Don't Agree Excellent COVID-19 Vaccine Catalysts Already Baked Into Share PriceSeeking Alpha • 11/20/20
Pfizer, Moderna COVID-19 Vaccines Could Get Limited EU Approval Before Year-End: ReportBenzinga • 11/20/20
Doctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus VaccinesThe Motley Fool • 11/20/20
Pfizer, Moderna to file FDA COVID-19 vaccine emergency usage as soon as FridayFox Business • 11/20/20
HHS Secretary Azar says Pfizer is expected to file FDA application for coronavirus vaccine Friday with Moderna soon to followCNBC • 11/19/20
A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should KnowThe Motley Fool • 11/19/20
Moderna's coronavirus vaccine doesn't need to be as icy cold as Pfizer's, and that could make it easier to distributeBusiness Insider • 11/18/20
Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Jefferies 2020 Virtual London Healthcare Conference (Transcript)Seeking Alpha • 11/18/20
Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?InvestorPlace • 11/18/20
Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.Business Insider • 11/18/20
2 Reasons Why Moderna's Coronavirus Vaccine Candidate Just Took the Lead Away from PfizerThe Motley Fool • 11/18/20
Could Moderna Become the Biggest Vaccine Company in the World Within 4 Years?The Motley Fool • 11/18/20
Moderna's vaccine maker identifies the 'big challenges' to mass producing the coronavirus vaccineCNBC • 11/18/20